Scarica l'app Stockscreener
8.42
3.57%
0.29
Precedente Chiudi:
$8.13
Aprire:
$8.14
Volume 24 ore:
105.19K
Relative Volume:
0.66
Capitalizzazione di mercato:
$426.46M
Reddito:
-
Utile/perdita netta:
$-29.42M
Rapporto P/E:
-9.6926
EPS:
-0.8687
Flusso di cassa netto:
$-25.01M
1 W Prestazione:
+0.84%
1M Prestazione:
+1.32%
6M Prestazione:
+54.50%
1 anno Prestazione:
+159.88%
Intervallo 1D:
$8.14
$8.47
Intervallo di 1 settimana:
$8.02
$8.78
Portata 52W:
$2.6801
$9.32
Eupraxia Pharmaceuticals Inc Stock (EPRX) Company Profile
Nome
Eupraxia Pharmaceuticals Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare EPRX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EPRX
Eupraxia Pharmaceuticals Inc
|
8.42 | 411.77M | 0 | -29.42M | -25.01M | -0.8687 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-26 | Iniziato | H.C. Wainwright | Buy |
| 2025-06-16 | Iniziato | Canaccord Genuity | Speculative Buy |
| 2025-02-21 | Iniziato | Craig Hallum | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
Eupraxia Pharmaceuticals Inc Borsa (EPRX) Ultime notizie
(EPRX) Daily Stock Insights (EPRX:CA) - Stock Traders Daily
(EPRX.WT.A) Equity Trading Insights - Stock Traders Daily
Will Eupraxia Pharmaceuticals Inc. benefit from rising consumer demandJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - mfd.ru
What’s the beta of Eupraxia Pharmaceuticals Inc. stockQuarterly Earnings Report & Risk Managed Trade Strategies - mfd.ru
Rate Hike: What are Eupraxia Pharmaceuticals Incs recent SEC filings showingWeekly Profit Report & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Is Eupraxia Pharmaceuticals Inc. a good stock for dollar cost averaging2025 Winners & Losers & Free Technical Pattern Based Buy Signals - mfd.ru
(EPRX) Stock Trading Blueprint (EPRX:CA) - Stock Traders Daily
Can Eupraxia Pharmaceuticals Inc. stock deliver sustainable ROEQuarterly Trade Report & Daily Profit Focused Stock Screening - mfd.ru
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Given Average Rating of "Buy" by Brokerages - MarketBeat
(EPRX.WT.A) Strategic Investment Guide - Stock Traders Daily
Risk Off: Is Eupraxia Pharmaceuticals Inc affected by consumer sentimentWeekly Earnings Recap & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Valuation Update: Can Eupraxia Pharmaceuticals Inc beat the S P 500July 2025 Reactions & Community Consensus Trade Signals - baoquankhu1.vn
Is HBOS plc Preferred Security forming a double bottomWeekly Earnings Recap & Real-Time Price Movement Reports - baoquankhu1.vn
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Stock Price Down 3.8%What's Next? - MarketBeat
(EPRX.WT.A) Advanced Trading Insights - Stock Traders Daily
Eupraxia Pharmaceuticals (TSX:EPRX) Trades With S&P/TSX Index - Kalkine Media
Here's Why We're Not At All Concerned With Eupraxia Pharmaceuticals' (TSE:EPRX) Cash Burn Situation - Yahoo Finance
(EPRX) Optimized Trading Opportunities (EPRX:CA) - Stock Traders Daily
(EPRX.WT.A) Trading Strategy and Analysis - Stock Traders Daily
(EPRX) Market Performance Analysis (EPRX:CA) - Stock Traders Daily
Fed Watch: Will Eupraxia Pharmaceuticals Inc stock hit new highs in YEAR - baoquankhu1.vn
(EPRX.WT.A) Investment Analysis (EPRX.WT.A:CA) - Stock Traders Daily
(EPRX) Technical Data (EPRX:CA) - Stock Traders Daily
Osteoarthritis Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Merck, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharma - Barchart.com
Osteoarthritis Pipeline 2025: MOA And ROA Insights, Clinical Trials Status, And Key Companies Involved By Delveinsight Merck, Peptinov, LG Chem, Akan Bioscience, Biotissue,Inc., Eupraxia Pharma - Menafn.com
Momentum Shift: Does Ainos Inc have strong fundamentalsPortfolio Value Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
(EPRX.WT.A) Technical Data (EPRX.WT.A:CA) - Stock Traders Daily
Gains Report: Will APWS stock hit new highs in YEARQuarterly Trade Report & Community Verified Watchlist Alerts - baoquankhu1.vn
Shorts Report: Will Eupraxia Pharmaceuticals Inc stock hit new highs in YEARTrade Signal Summary & Verified Trade Idea Suggestions - baoquankhu1.vn
Eupraxia Pharmaceuticals (OTCMKTS:EPRXF) Trading Down 0.1% – Time to Sell? - Defense World
Market Overview: What is Eupraxia Pharmaceuticals Incs valuation compared to sectorMarket Activity Report & Community Verified Watchlist Alerts - baoquankhu1.vn
(EPRX.WT.A) Dynamic Trading Report - Stock Traders Daily
Risk Report: Whats the beta of Eupraxia Pharmaceuticals Inc stock2025 Macro Impact & AI Powered Market Entry Strategies - baoquankhu1.vn
Targets Report: Is PNFP a top pick in the sectorJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - baoquankhu1.vn
(EPRX) Strategic Market Analysis (EPRX:CA) - Stock Traders Daily
Aug Retail: What are Eupraxia Pharmaceuticals Incs recent SEC filings showingWeekly Trade Report & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Aug Catalysts: Will Eupraxia Pharmaceuticals Inc benefit from rising consumer demand2025 Market Overview & Smart Swing Trading Alerts - baoquankhu1.vn
(EPRX) Trading Advice (EPRX:CA) - Stock Traders Daily
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Price Target Raised to $19.00 at Cantor Fitzgerald - Defense World
Cantor Fitzgerald Raises Eupraxia Pharmaceuticals (NASDAQ:EPRX) Price Target to $19.00 - MarketBeat
Cantor Fitzgerald raises Eupraxia Pharmaceuticals stock price target to $19 By Investing.com - Investing.com UK
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Receives Average Rating of "Buy" from Analysts - MarketBeat
Eupraxia Pharmaceuticals (TSX:EPRX) Price Target Increased by 21.11% to 14.96 - Nasdaq
Short Interest in Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Grows By 138.8% - MarketBeat
Eupraxia Pharmaceuticals (EPRX) Price Target Increased by 21.61% to 10.82 - Nasdaq
(EPRX.WT.A) Investment Performance Report - Stock Traders Daily
Trend Report: What is Eupraxia Pharmaceuticals Incs valuation compared to sectorMarket Trend Review & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Trading Action: Will Eupraxia Pharmaceuticals Inc benefit from rising consumer demandMarket Trend Summary & High Conviction Buy Zone Picks - baoquankhu1.vn
Macro Review: Can Eupraxia Pharmaceuticals Inc grow without dilution2025 Institutional Moves & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Trend Tracker for (EPRX) (EPRX:CA) - Stock Traders Daily
(EPRX) Trading Strategy and Analysis (EPRX:CA) - Stock Traders Daily
Eupraxia Pharmaceuticals Inc Azioni (EPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):